The talks on drugs including Novo Nordisk's Wegovy, GSK's Trelegy Ellipta, and Pfizer's Xtandi will set Medicare prices that ...
The drugs treat prostate, breast and blood cancers. About 80,000 people with Medicare Part D coverage used them in a one-year ...
Researchers at Oregon Health & Science University have uncovered how a molecule found on certain bacteria may drive blood ...
The price negotiations for the additional 15 drugs selected will be handled by the incoming Trump administration and, if ...
The Biden administration released another list of prescriptions drugs that would be subject to price controls. The price controls for the selected drugs will become effective in 2027.